These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15039470)
1. Tumor lysis syndrome following a single dose of capecitabine. Kurt M; Eren OO; Engin H; Güler N Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470 [No Abstract] [Full Text] [Related]
2. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon. Ghosal N; Misra V Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468 [No Abstract] [Full Text] [Related]
4. Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer. Han HS; Park SR; Kim SY; Park YI; Lee JS; Kook MC; Choi IJ; Kim CG; Lee JR; Cho SJ; Kim NK J Clin Oncol; 2008 Feb; 26(6):1006-8. PubMed ID: 18281674 [No Abstract] [Full Text] [Related]
5. [A woman with palmar and plantar hyperpigmentation]. van Tienhoven G; Wilmink JW Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578 [TBL] [Abstract][Full Text] [Related]
6. Nursing considerations for capecitabine-based combination therapy. Becze E ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236 [No Abstract] [Full Text] [Related]
7. [Tumor specific therapy. Targeted breast cancer therapy]. MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603691 [No Abstract] [Full Text] [Related]
9. Lethal toxicity of capecitabine due to abusive folic acid prescription? Clippe C; Freyer G; Milano G; Trillet-Lenoir V Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):299-300. PubMed ID: 12924465 [No Abstract] [Full Text] [Related]
10. The use of capecitabine in cancer: management of the hand foot syndrome. Sudoyo AW Acta Med Indones; 2005; 37(3):174-6. PubMed ID: 16110178 [No Abstract] [Full Text] [Related]
11. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen]. González-Haba E Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455 [No Abstract] [Full Text] [Related]
12. Coronary spasm induced by capecitabine. Schnetzler B; Popova N; Collao Lamb C; Sappino AP Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636 [No Abstract] [Full Text] [Related]
13. Capecitabine and PPE syndrome: a case report. LoRusso PM Breast J; 2003; 9(1):64-5. PubMed ID: 12558679 [No Abstract] [Full Text] [Related]
14. Severe hypertriglyceridaemia associated with the use of capecitabine. Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760 [No Abstract] [Full Text] [Related]
15. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature. Bar-Sela G; Haim N Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989 [TBL] [Abstract][Full Text] [Related]
16. Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer. Bell KA; Perna AG; Hsu S J Am Acad Dermatol; 2001 Nov; 45(5):790-1. PubMed ID: 11606938 [No Abstract] [Full Text] [Related]
17. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer. Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713 [TBL] [Abstract][Full Text] [Related]
18. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma. Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387 [No Abstract] [Full Text] [Related]
19. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report]. Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689 [No Abstract] [Full Text] [Related]